Fidelis Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-427
| Closed | -$257K | – | 464 |
|
|
2025
Q1 | $257K | Sell |
427
-20
| -4% | -$12.1K | 0.03% | 351 |
|
|
2024
Q4 | $298K | Sell |
447
-54
| -11% | -$36K | 0.03% | 333 |
|
|
2024
Q3 | $472K | Sell |
501
-33
| -6% | -$31.1K | 0.06% | 243 |
|
|
2024
Q2 | $570K | Buy |
534
+114
| +27% | +$122K | 0.08% | 195 |
|
|
2024
Q1 | $404K | Buy |
420
+56
| +15% | +$53.9K | 0.06% | 237 |
|
|
2023
Q4 | $320K | Buy |
+364
| New | +$320K | 0.07% | 236 |
|